National Institute for Research in Reproductive Health
(Indian Council of Medical Research)
and
Indian Society for the Stu...
Scientific Programme Committee
Deshratn Asthana (Univ of Miami, USA), D Bachani (NACO, New Delhi, India), Donta
Balaiah (N...
therapeutic drugs and preventive tools such as vaccines and microbicides. In addition to
these daunting bottlenecks in the...
of serodiscordant couples and clinical trials of microbicides and vaccine. The session on
service delivery for prevention ...
Scientific Programme
The scientific programme will include plenary lectures, lectures from invited
speakers and oral /post...
Registration Fees
Before
December 31, 2010
After
January 1, 2011
Indian Delegates
ISSRF Members
Students
Delegates from
Ov...
of 6

National Institute for Research in Reproductive Health (Indian ...

Published on: Mar 3, 2016
Published in: Health & Medicine      
Source: www.slideshare.net


Transcripts - National Institute for Research in Reproductive Health (Indian ...

  • 1. National Institute for Research in Reproductive Health (Indian Council of Medical Research) and Indian Society for the Study of Reproduction and Fertility Patrons : Dr Vishwa Mohan Katoch Secretary to the Government of India Department of Health Research Ministry of Health and Family Welfare and Director General, Indian Council of Medical Research, New Delhi Dr Jack Whitescarver NIH Associate Director for AIDS Research and Director, Office of AIDS Research, National Institutes of Health, Bethesda, USA Chairman, : Prof Nirmal Kumar Ganguly Scientific Programme Distinguished Biotechnology Fellow and Committee Advisor, Translational Health Science and Technology Institute, New Delhi Conveners : Dr Sanjiva D Kholkute Director National Institute for Research in Reproductive Health, ICMR, Mumbai Dr Chander P Puri CEO, Yashraj Biotechnology Ltd, Navi Mumbai Organizing Secretary : Dr Atmaram H. Bandivdekar Assistant Director (Scientist D) National Institute for Research in Reproductive Health, ICMR, Mumbai
  • 2. Scientific Programme Committee Deshratn Asthana (Univ of Miami, USA), D Bachani (NACO, New Delhi, India), Donta Balaiah (NIRRH, Mumbai, India), Nomita Chandiok (ICMR, New Delhi, India), Sanjay L Chauhan (NIRRH, Mumbai, India), Shekhar Chakraborty (NICED, Kolkata, India), Alaka Deshpande (JJ Hospital, Mumbai, India), Henry Gabelnik (CONRAD, USA), Rajat Goyal (IAVI, New Delhi, India), Shahid Jameel (ICGEB, New Delhi, India), Altaf Lal (MSD Wellcome Trust Hilleman Laboratories, India), N K Lohiya (ISSRF, Jaipur, India), Yvonne T Maddox (NIH, USA), Sanjay Mehendale (NARI, Pune, India), Debashis Mitra (NCCS, Pune, India), K V R Reddy (NIRRH, Mumbai, India), S Samathanam (DST, New Delhi, India), K. Satyanaryana (ICMR, New Delhi, India), B N Saxena (New Delhi, India), Jayanthi S Shashtri (Nair Hospital, Mumbai, India), R S Sharma (ICMR New Delhi, India), S Sinha (DBT, New Delhi, India) Local Organizing Committee Chairperson : Dr Smita Mahale Shrikant Betrabet, Meena Desai, Shanti Ganeshan, Taruna Gupta, Beena Joshi, Ikram Khatkhatey, Ragini Kulkarni, Jayanti Mania, Deepak Modi, Saritha Nair, Jacientha Periera, Priyanka Parte, Bhakti Pathak, A Pasi, Kedar Raikar (Goa), Geetanjali Sachadeva, Lalita Savardekar, Vandana Vernekar Dear Colleagues, The number of people living with HIV worldwide has grown to alarming proportions in recent years with more than 25 million people including adults and newborns having succumbed to AIDS till date. AIDS-related illnesses are projected to cause significant premature mortality in the coming decades. Consistent viral variation, differential immunological responses in host, viral affinity to different receptors and resistance to therapies have been recognized as the major impediments in developing effective
  • 3. therapeutic drugs and preventive tools such as vaccines and microbicides. In addition to these daunting bottlenecks in the area of fundamental and clinical research on HIV/AIDS, other issues, which warrant urgent attention, are lack of focused HIV prevention programmes for key populations and integrated programmes specifically designed for people living with HIV. There is pressing need to fill up the research gaps in our knowledge about the prevention approaches among older adults, serodiscordant couples and determinants of vulnerability among young people such as intergenerational partnerships. The International Conference on “Emerging Frontiers and Challenges in HIV/AIDS Research” aims to provide an interactive forum to the researchers who have been engaged in addressing the cutting edge researchable issues such as mode and mechanism of HIV infection and transmission; resistance to the pathogen as well as anti-HIV drugs; disease progression; and development of efficacious strategies for prevention, diagnosis and treatment of HIV/AIDS. The meeting will dwell on the key roadblocks to translational research in the field of HIV/AIDS which includes inconclusive knowledge of the basic mechanism of HIV pathogenesis, nature of the cellular and anatomical reserviores of virus infection, limitation of non human primate models and lack of consensus in the appropriate models for vaccine research and product testing. Special sessions on the policymaking and advocacy for the programmes on control and management of HIV/AIDS will be the other highlights of this international meet. This meeting is expected to create an excellent convergence of the perspectives of those with specific interests in fundamental, clinical and sociobehavioural research on HIV/AIDS. We earnestly hope that the deliberations during the conference will help in translating theoretical advances into the clinical practices and contribute towards deaccelerating the pace of this pandemic. The basic science sessions will focus on the impact of pathogenic diversity and host response on transmission and progression of the disease, preclinical testing of anti HIV drugs, microbicides and vaccines. The clinical science sessions will cover antiretroviral therapies, resistance to drug therapy, limitations in HIV diagnosis, counseling and testing
  • 4. of serodiscordant couples and clinical trials of microbicides and vaccine. The session on service delivery for prevention and management of HIV/AIDS will address role of private, NGO and public sectors in HIV service delivery; linked services of HIV with SRH including contraception and tuberculosis programme; and operational research. The session on HIV/AIDS Epidemiology will address HIV incidence including methods of assay; arriving at HIV estimates; HIV surveillance; impact of STI control on HIV epidemic and impact of increased access to treatment on epidemiological trends. Socio- behavioral science session will address the challenges in reducing the stigma, male involvement, sexuality and gender, and enhancing the community involvement in control of HIV/AIDS. On behalf of the organizers of the committee I am pleased to invite you to actively participate in the conference and contribute towards defining a more focused and comprehensive research goal to thwart the pandemic of HIV/AIDS. Dr A. H. Bandivdekar Assistant Director and Scientist D National Institute for Research in Reproductive Health, ICMR, Mumbai
  • 5. Scientific Programme The scientific programme will include plenary lectures, lectures from invited speakers and oral /poster sessions covering the following major themes Basic Research • HIV Variants and Pathogenesis • Host Genetic Factors • Vaccine Development and Testing • Microbicide Development and Evaluation • Animal Models to study HIV Pathogenesis • Molecular Targets and Drug Discovery Clinical Research • Antiretroviral Therapy • Preventive and Therapeutic Regimens • HIV with Opportunistic and Associated Infections • Parent to Child Transmission of HIV • Challenges in Estimation of HIV prevalence • Point of Care Assays for HIV Detection Socio-behavioral Research • Stigma and Discrimination for PLHIV • Male involvement including Gender based violence and alcoholism • HIV and SRH • Management of Children of Infected Individuals • Role of Public, Private and NGO in HIV Service Delivery • Most at Risk Population for HIV Transmission Presentations The International scientific programme committee will identify speakers for Plenary and invited lectures. Besides this, scientists are encourage to submit their abstracts for oral and poster presentations. Size of the poster will be of 3 x 4 ft LCD/Slide projectors will be made available at the venue Submission of Abstract The abstract of about 300 words typed on a plain paper using Microsoft word (12pt, Times New Roman) to be sent by email to the Organizing Secretary by November 30, 2010
  • 6. Registration Fees Before December 31, 2010 After January 1, 2011 Indian Delegates ISSRF Members Students Delegates from Overseas Rs 5000/- Rs 3500/- Rs 1500/- US $ 350/- Rs 6000/- Rs 4000/- Rs 2000/- US $ 400/- Registration fees may be paid through bank draft/cheque payable to “International Conference on HIV/AIDS” Venue Marriott Hotels India Pvt Ltd P O Box 8283, Juhu Tara Road, Mumbai 400 049, INDIA Phone 91-22-66933014 FAX 91-22-6693 3023 Accommodation Accommodation can be arranged in various categories of hotels of international standards and other guest houses to suit your budgetary requirements. In the event you need any assistance for booking accommodation please contact us. Further Information and Correspondence Dr A. H. Bandivdekar Assistant Director (Scientist D) National Institute for Research in Reproductive Health (Indian Council of Medical Research) J. M. Street, Parel, Mumbai 400 012 INDIA Tel No. 91-22-24192021, 24192138 Fax No. 91-22-24139412 Mobile No. 91-9869027186 Email : hivconf2011@gmail.com batmaram@gmail.com

Related Documents